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Abstract: Carbon dots (CDs) are engineered nanoparticles that are used in a number of bioapplications
such as bioimaging, drug delivery and theranostics. The effects of CDs on the immune system have
not been evaluated. The effects of CDs on the immune system were assessed by using RAW 264.7 cells
and whole blood cell cultures. RAW cells were exposed to CD concentrations under basal conditions.
Whole blood cell cultures were exposed to CD concentrations under basal conditions or in the
presence of the mitogens, lipopolysaccharide (LPS) or phytohaemmagglutinin (PHA). After exposure,
a number of parameters were assessed, such as cell viability, biomarkers of inflammation, cytokine
biomarkers of the acquired immune system and a proteome profile analysis. CDs were cytotoxic to
RAW and whole blood cell cultures at 62.5, 250 and 500 µg/mL, respectively. Biomarkers associated
with inflammation were induced by CD concentrations ≥250 and 500 µg/mL under basal conditions
for both RAW and whole blood cell cultures, respectively. The humoral immune cytokine interleukin
(IL)-10 was increased at 500 µg/mL CD under both basal and PHA activated whole blood cell culture
conditions. Proteome analysis supported the inflammatory data as upregulated proteins identified
are associated with inflammation. The upregulated proteins provide potential biomarkers of risk that
can be assessed upon CD exposure.
Keywords: carbon dots; cytotoxicity; induced inflammation
1. Introduction
In 2004, carbon dots (CDs) were accidentally discovered when they were isolated from
single-walled carbon nanotubes (SWCNTs) via gel electrophoresis [1]. CDs, also known as
carbon quantum dots or carbon nanoparticles, are a relatively new fluorescent quasi spherical,
zero-dimensional nanomaterial with a diameter less than 10 nm [2–4]. Recently, there has been
an increase in CD popularity as they possess unique optical properties, biocompatibility, low toxicity,
facile synthesis and aqueous stability [1,3,5]. These unique properties have allowed CDs to be used in
bioapplications such as bioimaging, drug delivery and theranostic developments [1].
Due to these applications, human exposure is unavoidable. However, very few studies have
evaluated the potential effects of CDs on cells and the immune system. In vivo and in vitro studies
have mainly focused on the sensing and bioimaging of cells via the photoluminescent properties
of CDs [6–9]. Only a few studies have reported on the toxicity of CDs, and these agree with the
reports of their low toxicity. However, the toxicity is dependent on the functionalization of the
CDs [10,11]. To our knowledge, no studies have reported on the effects of CDs on the immune system.
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Reports have been published on the effects of carbon nanotubes (CNTs) on the immune system [12–14].
In these studies, CNTs were reported to induce allergic airway inflammation, pulmonary inflammation,
and inflammatory cytokines, interleukin 1β (IL-1β) and interleukin 6 (IL-6) under both in vivo and
in vitro conditions.
This current study aimed to evaluate the effects of CDs on the murine macrophage cell line,
RAW 264.7 and human whole blood cell cultures (WBCs). A number of parameters were assessed,
which include cell viability, inflammatory biomarkers, cytokines of the acquired immune system and
a proteome profile analysis.
2. Materials and Methods
2.1. Synthesis and Characterization of Carbon Dots (CDs)
The CDs were obtained from the University of Missouri where they were synthesized and
characterized as previously published by Bayati et al. [2]. Briefly, transmission electron microscopy
(TEM) (JEOL 1400, Peabody, MA, USA) (Figure A1) revealed an average size range of 1–3 nm and
an average zeta potential of −16.83 ± 1.40 mV at a neutral pH in 1 mM sodium chloride (NaCl)
(Figure A2 and Table A1).
2.2. Preparation of CD Stock Solutions
A 10 mg/mL stock solution of CDs in distilled water was prepared. The CDs were sonicated
in short intermittent bursts on ice for approximately 5 min (QSonica, LLC. Misonix sonicators,
XL-200 Series, Newtown, CT, USA). The CDs were sonicated prior to use in cultures.
2.3. RAW 264.7 Cells
2.3.1. RAW 264.7 Macrophage Assay
The murine macrophage cell line, RAW 264.7, was obtained from the American Type Culture
Collection (ATCC TIB-71, Manassas, VA, USA). The RAW 264.7 cells were cultured in Dulbecco’s
modified Eagle’s medium (DMEM, Lonza, Cape Town, South Africa) supplemented with 10%
heat inactivated fetal bovine serum (FBS, Hyclone, Little Chalfont, UK), glutamax (Sigma-Aldrich,
St. Lousi, MO, USA), antibiotic/antimycotic (Sigma-Aldrich) and gentamicin (Sigma-Aldrich). The cells
were incubated in a humidified atmosphere of 5% CO2 at 37 ◦C and the cells were sub-cultured every
2–3 days.
The RAW 264.7 cells (1 × 105 cells/mL) were cultured in cell culture-treated 48-well plates
and incubated in a humidified atmosphere of 5% CO2 at 37 ◦C for approximately 48 h until
the cells reached 80–90% confluence. After the incubation period, the media was removed and
replaced with media containing 2.5% FBS. The subsequent procedures occurred in serum free media.
The cells were pre-exposed for 2 h to various concentrations of CDs. Thereafter, the cells were left
unstimulated and a positive control was also present. The positive control was cells only stimulated
by lipopolysaccharide (LPS) (1 µg/mL) without the presence of nanoparticle. The final concentration
of FBS/well was 0.5%. Cultures were incubated overnight (~18 h) under standard tissue culture
conditions. Culture supernatants were collected and used for nitric oxide (NO), interleukin 6 (IL-6),
macrophage inflammatory protein 1α (MIP-1α), MIP-1β, MIP-2 and proteome profiling analysis.
2.3.2. Cytotoxicity Assay
After the removal of the supernatants, cells were washed with Dulbecco’s phosphate
buffered saline (DPBS) (Lonza), supplemented with glutamax and antibiotic/antimycotic solution.
Cytotoxicity was measured by adding 150 µL of a 1/10 dilution of 2-(4-Iodophenyl)-3-(4-nitrophenyl)-
5-(2,4-disulfophenyl)-2H-tetrazolium (WST-1, Roche, Basel, Switzerland) reagent in serum-free
medium to each well. Metabolically active cells convert WST-1 reagent to a formazan that can
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be measured spectrophotometrically. Formazan formation was determined by reading the plate at
450 nm (Multiskan Ex, Thermo Electron Corporation, Waltham, MA, USA) immediately after WST-1
addition and again after an incubation period of 1 h at 37 ◦C. The increase in absorbance at 450 nm
is proportional to formazan formation. The level of fomazan formed is directly proportional to
cell viability.
2.3.3. NO Determination
After the overnight incubation of the RAW 264.7 cells, the amount of nitrite that was produced
by the cells was measured in the culture supernatant as an indication of NO production. The NO
assay is based on the Griess reaction [15]. In this study, the NO assay is used to determine the
amount of nitrite ion produced as a metabolite of NO. This was measured against a doubling
dilution range of a 100 µM nitrite standard (Sigma-Aldrich). Nitrite standards or culture supernatant
collected (100 µL) were mixed with 100 µL of Griess reagent (1:1 of 1% sulfanilamide and
0.1% naphtylethlemidimine-dihydrochloride in 2.5% phosphoric acid) (all reagents obtained from
Sigma-Aldrich). Thereafter, the plate was incubated at room temperature for 15 min. The absorbance
was read at 540 nm using a microplate reader (Multiskan Ex, Thermo Electron Corporation) and the
amount of NO produced by the RAW cells quantified.
2.3.4. Mouse IL-6 Double Antibody Sandwich (DAS) Enzyme Linked Immunosorbent Assay (ELISA)
The mouse IL-6 ELISA (e-Bioscience, Ready-Set-Go, Waltham, MA, USA) kits were used to
measure IL-6 cytokine levels in the cell culture supernatants. The LPS-stimulated control was assayed
at (1/40 v/v) while the negative control (not treated with LPS) was assayed at (1/5 v/v) in assay
diluent. Assays were performed in 96-well Nunc maxisorb plates. The kit contained all the reagents
for the assay and was performed as per the manufacturer’s instructions.
2.3.5. Mouse MIPs (MIP-1α, MIP-1β and MIP-2) DAS ELISAs
Mouse MIP-1α, MIP-1β and MIP-2 ELISAs (R & D Systems, Minneapolis, MN, USA) were
performed on the samples and the LPS-stimulated culture supernatants. The kits contained all the
reagents required for the experiment and experiments were performed as per the manufacturer’s
instructions. The samples were all diluted in reagent diluent, 1% human serum albumin (HSA) (w/v).
The MIP-1α in unstimulated samples were assayed at 1/270 v/v and the LPS stimulated supernatant
at 1/2000 v/v in diluent. For the MIP-1β ELISA, the unstimulated culture supernatants were assayed
at 1/100 v/v while the LPS stimulated supernatants were assayed at 1/5000 v/v in diluent. The MIP-2
ELISA unstimulated supernatants were assayed at 1/20 v/v and the mitogen stimulated supernatant
was at 1/500 v/v in assay diluent.
2.3.6. Mouse Proteome Profiling Assay
A commercially available antibody array kit (Proteome Profiler, Mouse cytokine Array Panel
A, R & D Systems) which was coated with 40 capturing antibodies in duplicate on a nitrocellulose
membrane (dot blot) was used. The kit contained all the reagents for the assay and was performed
as per the manufacturer’s instructions. This cytokine and chemokine antibody array was used to
determine the effects of CD exposure on cytokine and chemokine synthesis by RAW 264.7 macrophage
cells. The assay required 500 µL of cell culture supernatants (unstimulated containing 0 µg/mL CDs,
LPS stimulated containing 0 µg/mL CDs, and unstimulated containing 500 µg/mL CDs). Membranes
were subjected to an ultra-sensitive chromogenic 3,3′,5,5′-Tetramethylbenzidine (TMB) membrane
substrate (Thermo Scientific, Waltham, MA, USA) to reveal sample–antibody complexes labeled with
streptavidin-HRP. Photographs were taken of the blots after the exposure to the substrate.
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2.3.7. Quantification of Pixel Density for Cytokine and Chemokine Membranes
Membrane images were quantified using image processing and analysis Java software (version
1.6.0_24, Oracle Corporation, Redwood city, CA, USA), ImageJ (version 1.4.3.67, National Institutes
of Health, Bethesda, MD, USA). Levels of cytokines and chemokines were expressed as a percentage
of the reference spot. Microsoft Excel (Manufacturer name, city, state abbreviation if US or Canada,
country) was used to calculate the percentage, which is expressed as mean ± standard deviation (SD).
2.4. Whole Blood Cell (WBC) Culture
2.4.1. Blood Collection
Blood was collected by a doctor/nurse from healthy males not using any medication. The blood
was collected using venipuncture directly into 3.2% sodium citrate vacuum tubes (Greiner bio-one,
Kremsmunster, Austria). The blood was processed immediately. The whole blood cell cultures were
performed under sterile conditions. Ethical clearance was obtained from the University of the Western
Cape (Ethics No. 10/9/43). Informed consent was also obtained from the participant.
2.4.2. Cell Culture
Human whole blood was diluted with RPMI-1640 media (Sigma-Aldrich) to give a 10% (v/v)
blood in medium mixture. Blood was either left unstimulated or stimulated with LPS (Sigma-Aldrich)
(0.1 µg/mL) or phytohaemmagglutinin (PHA) (Sigma-Aldrich) (1.6 µg/mL). Unstimulated or
stimulated whole blood cell cultures were incubated overnight at 37 ◦C with high, intermediate and low
concentrations of CDs in 24-well tissue culture treated plates (Nunc). A positive cytotoxicity control
(medium containing 0.01% v/v Tween20 (Merck, Modderfontein, South Africa) was also present.
After the incubation period, the culture supernatants were collected and assayed for cytotoxicity,
cytokines and chemokines.
2.4.3. Cytotoxicity Assay
Cytotoxicity was measured by monitoring lactate dehydrogenase (LDH) release by damaged cells.
LDH activity was monitored spectrophotometrically using an LDH kit (LDH-cytotoxicity colourometric
kit II, BioVision, Milpitas, CA, USA). The kit contained all the reagents required for the assay and
assays were performed as per the manufacturer’s instructions.
2.4.4. Cytokine Analysis using DAS ELISAs
Commercially available kits (e-Bioscience, Ready-Set-Go) were used to analyze the level of
cytokine secretion from the whole blood cell cultures. The kits were used as per the manufacturer’s
instructions and contained all the reagents to complete the assay. The unstimulated and LPS stimulated
samples were analysed using a 1/10 dilution for the IL-6 assay. While the unstimulated and PHA
stimulated samples were assayed neat for IL-10 and interferon gamma (IFNγ) analysis. The same
protocol was used as previously described for the mouse cytokine ELISA.
2.4.5. Human MIP-1β DAS ELISA
A human MIP-1β ELISA (R & D Systems) was performed on the unstimulated and LPS stimulated
culture supernatants of the WBCs. The samples were diluted 1/10 in reagent diluent, 0.1% v/v bovine
serum albumin (BSA) (Sigma). The same protocol was followed as for the mouse MIPs ELISAs.
2.4.6. Human Proteome Profiling
A commercially available antibody array kit (Proteome Profiler, Human Cytokine Array Kit,
R & D Systems) which was coated with 36 capturing antibodies in duplicate on a nitrocellulose
membrane (dot blot) was used. The kit contained all the reagents for the assay and was performed
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as per the manufacturer’s instructions. This cytokine and chemokine antibody array was used to
determine the effects of CD exposure on cytokine and chemokine secretion by WBCs. The assay
required 500 µL of cell culture supernatants (unstimulated containing 0 µg/mL CDs, LPS stimulated
containing 0 µg/mL CDs, and unstimulated containing 500 µg/mL CDs). The subsequent steps were
carried out as described for the mouse cytokine and chemokine proteome profiling.
2.5. Statistical Analysis
All experiments were performed in triplicate and the data was calculated using Microsoft Excel.
Data is presented as mean ± standard deviation (SD). One-way analysis of variance (ANOVA) using
SigmaPlot 12.0 (Systat Software Inc., San Jose, CA, USA) was used to assess statistical differences with
p < 0.01 being deemed significant.
3. Results
3.1. The Effects of CDs on RAW 264.7 Cells
3.1.1. The Effects of CDs on the Viability of RAW 264.7 Cells
RAW cell viability, under basal conditions was significantly reduced (p < 0.001) by CD
concentrations of 62.5 and 250 µg/mL compared to the culture control (Figure 1). However, viability
was notably upregulated (p < 0.001) at 31.25 µg/mL CD compared to the positive control (LPS only).
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Figure 1. Cell viability of RAW 264.7 macrophage cells exposed to carbon dots (CDs). Data represents
mean ± SD. with n = 9. Bars marked with letters indicate significant differences (p < 0.01). Significance.
demarcated by: a—significantly different (p < 0.001) compared to 0 µg/mL CD control, b—significantly
different (p < 0.001) compared to lipopolysaccharide (LPS)-stimulated 0 µg/mL CD control.
3.1.2. The Effects of CDs on the Inflammatory Biomarker NO Using RAW 264.7 Cells
CDs at the concentrations tested, had no effect on NO production by unstimulated RAW 264.7 cells
(Figure 2a). RAW cells treated with LPS in the absence of CDs were included as a positive control
for inflammation.
3.1.3. The Effects of CDs on the Inflammatory Biomarker IL-6 Using RAW 264.7 Cells
CD concentrations ≤ 31.25 µg/mL had no effect on IL-6 in an unstimulated environment
(Figure 2b). However, CD concentrations ≥ 62.5 µg/mL significantly (p < 0.001) ar ally i hibited
IL-6 synthesis from cells under basal conditions compared to the culture control. The positive control
(56,748 ± 9591.8 pg/mL IL-6) is not included on the figure.
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3.1.4. The Effects of CDs on MIP-1α Using RAW 264.7 Cells
CD concentrations ≤ 31.25 µg/mL did not affect MIP-1α synthesis from RAW cells under
unstimulated conditions (Figure 2c). However, CD concentrations ≥ 62.5 µg/mL significantly
upregulated (p < 0.002) MIP-1α synthesis under basal conditions compared to the culture control.
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(MIP)‐1α; (d) MIP‐1β and (e) MIP‐2 production of unstimulated RAW 264.7 cell cultures exposed to 
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Figure 2. Murine macrophage, RAW 264.7 cells after treatment with CDs. Parameters assessed: (a) nitric
oxide (NO) levels; (b) interleukin (IL)-6 production; (c) macrophage inflammatory protein (MIP)-1α;
(d) MIP-1β and (e) MIP-2 production of unstimulated RAW 264.7 cell cultures exposed to CDs. Data
represents mean ± SD with n = 9. Bars marked with letters indicate significant differences (p < 0.01).
Significance demarcated by a: significantly different (p < 0.001), compared to the LPS stimulated
0 µg/mL CD control.
3.1.5. The Effects of CDs on MIP-1β Using RAW 264.7 Cells
MIP-1β synthesis was not affected by CD concentrations ≤ 125 µg/mL (Figure 2d).
CD concentrations ≥ 250 µg/mL significantly upregulated (p < 0.001) MIP-1β synthesis from
RAW cells under basal conditions compared to the culture control. The positive control,
LPS (343,965 ± 52,044 pg/mL MIP-1β) is not presented on Figure 2d.
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3.1.6. The Effects of CDs on MIP-2 Using RAW 264.7 Cells
MIP-2 synthesis from RAW cells exposed to CD concentrations mimicked the MIP-1β data under
basal conditions (Figure 2d). MIP-2 was unaffected by CD concentrations ≤ 125 µg/mL (Figure 2e).
However, CD concentrations ≥ 250 µg/mL significantly upregulated (p < 0.001) MIP-2 synthesis from
RAW cells under unstimulated conditions. The positive control (302,089 ± 68,868 pg/mL MIP-2) is not
presented in Figure 2e.
3.2. The Effects of CDs on the Secretory Cytokine and Chemokine Profile of RAW 264.7 Cells
Membranes exposed to culture supernatants of RAW 264.7 cells exposed to media only, media in
the presence of a mitogen, and 500 µg/mL CDs in the absence of a mitogen allowed for the analysis of
various cytokines and chemokines expressed by the cells upon exposure (Figure 3). Quantification
of the membranes showed that RAW cells exposed to media containing LPS allowed the cells to
synthesize certain proteins that were not synthesized by cells exposed to media only and 500 µg/mL
CDs (Table 1). These proteins include macrophage colony-stimulating factor (M-CSF), interleukin
27 (IL-27) and interleukin 1 β (IL-β).
Similarly, certain proteins were significantly upregulated (p < 0.001) by cells exposed to
500 µg/mL CD compared to cells exposed to media only. These proteins include IFNγ-inducible
protein 10 (IP-10), granulocyte-colony stimulating factor (G-CSF), tumor necrosis factor α (TNF-α),
granulocyte–macrophage colony-stimulating factor (GM-CSF), IL-6, monocyte chemoattractant protein
1 (MCP-1)/JE gene of mouse fibroblasts, MIP-1α, MIP-1β, MIP-2, intracellular adhesion molecule
1 (ICAM-1) and interleukin 1 receptor antagonist (IL-1ra).
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Figure 3. The effect of CDs on RAW 264.7 cells. Cells were incubated with (a) media only
(negative control); (b) media in the presence of LPS and (c) 500 µg/mL CDs in the absence of
a mitogen. Supernatants were probed using the proteome profiler array as described in methods.
Cytokines/chemokines that were detected were allocated numbers: 1, 3, and 16 are reference
spots; 2—IFNγ-inducible protein (IP)-10; 4—granulocyte-colony stimulating factor (G-CSF); 5—tumor
necrosis factor (TNF)-α; 6—granulocyte–macrophage colony-stimulating factor (GM-CSF); 7—IL-6;
8—JE; 9—intracellular adhesion molecule (sICAM)-1; 10—MIP-1α; 11—MIP-1β; 12—IL-1β; 13—MIP-2;
14—interleukin 1 receptor antagonist (IL-1ra); 15—regulated on activation, normal T cell expressed
and secreted (RANTES); 17—IL-27; 18—stromal cell-derived factor 1 (SDF-1).
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Table 1. Quantification of cytokines and chemokines secreted by RAW 264.7 cultures not stimulated
with LPS after treatment with medium only, medium containing LPS or medium containing 500 µg/mL
carbon dots (CDs). Membranes subjected to chromogenic exposure. Data is represented as mean ± SD.
Significance indicated by a CD at 500 µg/mL significantly different compared to negative control
(p < 0.001), b CD at 500 µg/mL significantly different compared to the positive control (p < 0.001).
Cytokines and Chemokines Positive Control Negative Control 500 µg/mL CDs
Reference Spot 100 ± 8.62 100 ± 10.49 100 ± 15.19
IP-10 114.74 ± 5.24 0 ± 0 8.20 ± 0.11 a,b
G-CSF 58.27 ± 2.55 0 ± 0 26.76 ± 0.51 a,b
TNF-α 102.01 ± 5.91 17.96 ± 0.13 101.00 ± 0.60 a
GM-CSF 47.32 ± 3.02 0 ± 0 3.72 ± 0.03 a,b
IL-6 91.94 ± 3.60 0 ± 0 0 ± 0 b
JE 78.97 ± 4.48 0 ± 0 10.47 ± 0.01 a,b
sICAM 109.05 ± 6.00 34.76 ± 0.02 78.65 ± 0.98 a,b
MIP-1α 72.87 ± 4.22 57.00 ± 1.94 64.87 ± 1.87 a,b
MIP-1β 62.77 ± 3.35 37.68 ± 0.33 45.40 ± 0.81 a,b
MIP-2 55.51 ± 2.75 0 ± 0 76.63 ± 0.06 a,b
RANTES 100.57 ± 4.42 17.93 ± 0.83 36.09 ± 0.78 a,b
SDF-1 16.41 ± 1.61 21.75 ± 1.01 0 ± 0 a,b
IL-27 54.97 ± 4.05 0 ± 0 0 ± 0 b
IL-1ra 55.84 ± 1.66 0 ± 0 14.96 ± 0.21 a,b
IL-1β 39.16 ± 3.31 0 ± 0 0 ± 0 b
3.3. The Effects of CDs on WBCs
3.3.1. The Effects of CDs on Viability of WBCs
CD concentrations ≤ 50 µg/mL did not affect WBC viability (Figure 4). However, significant
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Figure 4. Cell viability of whole blood cells (WBCs) exposed to CDs. Data represents mean ± SD
with n = 4. Bars marked with letters indicate significant difference (p < 0.01) to control. Significance
demarcated by a: significantly different (p < 0.002) compared to 0 µg/mL CD control.
3.3.2. The Effects of CDs on the Inflammatory System Biomarker IL-6 Using WBCs
CD concentrations ≤ 50 µg/mL did not affect IL-6 levels in cultures not stimulated with LPS
(Figure 5a). However, at 500 µg/mL CD significantly induced the upregulation (p < 0.001) of IL-6 in
unstimulated cultures. Cultures exposed to CD concentrations in the presence of LPS did not affect the
synthesis of IL-6.
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Figure 5. The inflammatory biomarker expression levels of whole blood cell cultures exposed to CDs.
Nanoparticles (NPs) in the absence or presence of LPS: (a) IL-6 expression levels and (b) MIP-1β
expression levels. Data represents mean ± SD with n = 4. Bars marked with letters indicate significant
differences (p < 0.01). Significance demarcated by: a—significantly different compared (p < 0.002) to
0 µg/mL CD control.
3.3.3. The Effects of CDs on the Inflammatory Chemokine, MIP-1β Using WBCs
MIP-1β synthesis followed the same trend as the IL-6 data for both the unstimulated and
stimulated cultures exposed to CDs. CD at concentrations tested had no effect on MIP-1β synthesis by
LPS stimulated WBCs (Figure 5b). At concentrations ≤ 50 µg/mL, CD did not affect MIP-1β synthesis
by unstimulated cells. However, CD at 500 µg/mL resulted in a significant (p < 0.001) stimulation of
MIP-1β synthesis by unstimulated WBCs.
3.3.4. The Effects of CDs on the Humoral Immune System Biomarker IL-10 Using WBCs
CD at 5 and 50 µg/mL did not affect the synthesis of IL-10 from unstimulated WBC cultures
(Figure 6a). However, significant levels (p < 0.001) of IL-10 was detected in the 500 µg/mL CD
unstimulated WBC culture compared to the negative control. PHA stimulated WBC at 5 and 50 µg/mL
had no effect on IL-10 produced by WBCs compared to the positive control. However, at 500 µg/mL
CD, the PHA stimulated WBC produced significantly more IL-10 compared to the positive control.
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expose to CDs in the absence or presence of phytohaemmagglutinin (PHA): (a) IL-10 expression levels
and (b) IFNγ expression levels. Data represents mean ± SD with n = 4. Significance demarcated by a:
significantly different (p < 0.001) compared to 0 µg/mL CD control, b: significantly different (p < 0.008)
compared to PHA stimulated 0 µg/mL CD control.
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3.4. The Effects of CDs on the Secretory Cytokine and Chemokine Profile of WBCs
The proteome profile of WBCs exposed to media only and media in the presences of LPS and
500 µg/mL CD in media only revealed the synthesis or inhibition of certain proteins (Figure 7).
Quantification of the membranes showed that certain proteins were significantly upregulated
(p < 0.001) in supernatants at WBCs incubated in the presence of 500 µg/mL CD compared to the
negative control (media only) (Table 2). These proteins include IL-1ra, macrophage migration inhibitory
factor (MIF), MIP-1α/β and IL-8. Cytokines and chemokines that were prominently down regulated
compared to the positive control include IL-1ra, MCP-1, MIP-1α/β, regulated on activation, normal
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Cytokines and Chemokines  Positive Control  Negative Control  500 μg/mL CDs   
Reference Spot  100 ± 7.28  100 ± 5.57  100 ± 11.35 
IL‐1ra  16.92 ± 1.46  0 ± 0  12.57 ± 1.27 a,b 
MIF  17.56 ± 1.51  10.57 ± 1.91  20.41 ± 4.00 a 
MCP‐1  26.26 ± 2.54  0 ± 0  0 ± 0 b 
Serpin E1  32.40 ± 2.49  24.26 ± 2.26  31.81 ± 4.38 
MIP‐1α/β  70.22 ± 4.11  0 ± 0  25.84 ± 2.17 a,b 
RANTES  62.94 ± 2.55  34.28 ± 1.37  32.95 ± 2.75 b 
sICAM  37.15 ± 0.59  35.98 ± 2.19  32.38 ± 4.52 
IL‐6  29.31 ± 4.81  0 ± 0  0 ± 0 b 
IL‐8  50.27 ± 8.41  0 ± 0  13.56 ± 2.53 a,b 
IL‐1β  20.29 ± 0.99  0 ± 0  0 ± 0 b 
 
Figure 7. The effects of CDs on whole blood cells. Cells were incubated with (a) media only; (b) media
and LPS; (c) 500 µg/mL CDs in the absence of LPS. Cytokines/chemokines that were detected were
allocated numbers: 1, 2, and 13 are reference spots; 3—IL-1ra; 4—macrophage migration inhibitory
factor (MIF); 5—MCP-1; 6—Serpin E1; 7—MIP-1α/β; 8—RANTES; 9—sICAM-1, 10—IL-6, 11—IL-8
and 12—IL-1β.
Table 2. Quantification of cytokines and chemokines secreted by Whole Blood Cells (WBCs) not
stimulated with LPS after treatment with medium only (negative control), medium containing LPS
(positive control) or medium containing 500 µg/mL CDs. Membranes were subjected to chromogenic
exposure. Data is represented as mean± SD. Significance indicated by a CDs at 500 µg/mL significantly
different (p < 0.01 compared to negative control, b CDs at 500 µg/mL significantly different (p < 0.001)
compared to the positive control.
Cytokines and Chemokines Positive Control Negative Control 500 µg/mL CDs
Reference Spot 100 ± 7.28 100 ± 5.57 100 ± 11.35
IL-1ra 16.92 ± 1.46 0 ± 0 12.57 ± 1.27 a,b
MIF 17.56 ± 1.51 10.57 ± 1.91 20.41 ± 4.00 a
MCP-1 26.26 ± 2.54 0 ± 0 0 ± 0 b
Serpin E1 32.40 ± .49 24.26 ± 2.26 31.81 4 38
MIP-1α/β 70.22 ± 4.11 0 ± 0 25.84 ± 2.17 a,b
RANTES 62.94 ± 2.55 34.28 ± 1.37 32.95 ± 2.75 b
sICAM 37.15 ± 0.59 35.98 ± 2.19 32.38 ± 4.52
IL-6 29.31 ± 4.81 0 ± 0 0 ± 0 b
IL-8 50.27 ± 8.41 0 ± 0 13.56 ± 2.53 a,b
IL-1β 20.29 ± 0.99 0 ± 0 0 ± 0 b
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4. Discussion
In recent years, CDs has attracted lots of interest due to their many bioapplications, such as
bioimaging, drug delivery and theranostics [1]. However, no studies have evaluated the effects these
CDs have on the immune system.
Exposing RAW cells to CD concentrations of 62.5 and 250 µg/mL reduced cell viability by less than
20%. Viability was also reduced in WBCs exposed to the highest concentration of CDs (500 µg/mL).
Due to the results seen in WBCs, future studies will investigate the effects of CD on WBC viability at
concentrations between 50 and 500 µg/mL. The results obtained in this study for both RAW cells and
WBCs supports previous reports of CDs having low toxicity levels [3,5]. Havrdova et al. (2016) found
that pristine CDs only induced morphological changes in cells at concentrations >200 µg/mL [10].
They also found that pristine CDs stimulated proliferation at very low concentrations, ranging from
5 to 50 µg/mL, and thereafter a decrease in viability, with an increase in concentration. This trend
was followed in this study as there was an increase in cell viability of the RAW cells at 31.25 µg/mL
and a reduction in viability at 62.5 and 250 µg/mL. This could be attributed to a high level of reactive
oxygen species leading to uncontrolled proliferation in the G2/M phase of the cell cycle.
Studies have mainly monitored the bioimaging of cells using CDs [6–8]. Wang et al. (2011)
evaluated the cytotoxic effects of CDs on two different cell types, HT-29 and MCF-7 [16]: cytotoxicity
was induced in both cell lines, although cytotoxicity was also dependent on the functionalization of the
CDs. However, Yang et al. (2009) had contradictory results to what was found by Wang et al. (2011) as
they reported no effects on all parameters monitored, using the same cell lines, but only poly(ethylene
glycol-amine) (PEG) functionalization of CDs [16,17]. The effects of SWCNTs on RAW cells was
evaluated and it was found that CDs induced oxidative stress [18]. However, Crouzier et al. (2010)
found that carbon nanotubes reduced oxidative stress in the lungs of mice [19].
Under basal conditions, the RAW cell inflammatory marker IL-6 was partially inhibited by CD
concentrations ≥ 62.5 µg/mL. However, NO remained unaffected by CD exposure. Contradictory
to the RAW cell inflammatory markers, the MIP chemokines were significantly upregulated by CD
exposure at concentrations ≥ 250 µg/mL. A similar trend was seen with the WBCs, where the
highest concentration assessed (500 µg/mL) induced IL-6 and MIP-1β in unstimulated cultures.
No studies have been conducted on the effects of CDs on the immune system. In vitro monocyte
cultures exposed to carbon nanotubes induced the formation of inflammatory genes IL-6 and IL-1β [16].
Kayat et al. (2011) and Crouzier et al. (2010) also found that carbon nanotubes induced inflammatory
markers [13,19]. Another study conducted by Murray et al. (2009) found that SWCNTs induced
pro-inflammatory cytokines such as IL-6, MCP-1 and TNF-α in dermal cells [20]. Zhang et al. (2012)
also found that RAW cells exposed to multi-wall carbon nanotubes (MWCNTs) induced inflammatory
proteins [21]. The induction of inflammatory markers was supported by the proteome profile analysis
of both RAW and WBCs. The inflammatory proteins induced included TNF-α, MIPs, MCP-1, IL-6,
IL-8, IL-1ra and IL-1β. However, Liu et al. (2012) found that CDs did not affect inflammatory genes
such as IL-6 and TNF-α [22].
The humoral immune response cytokine IL-10 was upregulated at 500 µg/mL CD in both
unstimulated and PHA stimulated cultures, whereas the cell mediated immune response cytokine IFNγ
remained unaffected under both conditions. The induction of IL-10 in unstimulated conditions would
provoke a humoral immune response, when one is not required and upregulated such a response
under stimulated conditions. This could lead to hypersensitivity and autoimmunity reactions [23].
5. Conclusions
This study clearly demonstrates that CDs are cytotoxic at high concentrations, although the
levels of cytotoxicity are low. CDs also induce inflammation under basal conditions at relatively
high concentrations, supported by the proteome analysis. The proteome analysis revealed potential
biomarkers to be assessed upon CD exposure. These include MIP-1α, MIP-1β, MIP-2, TNF-α, IL-8 and
SDF-1. The humoral immune response is also modulated at high levels of CDs. This stimulation of
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immune responses could lead to hypersensitivity and autoimmunity [23]. The current study provides
an important insight into the effects of CDs on the immune system as these nanoparticles are geared to
be used in vivo for a number of bioapplications.
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Figure A1. Visualization of carbon dots via transmission electron microscopy (TEM).
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Figure A2. Zeta potential of carbon dots under varying pH levels, while maintaining a constant ion
concentration of 10 mM NaCl.
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Table A1. Average size of carbon dots, under varying pH levels, while maintaining a constant ion
concentration of 10 mM NaCl.
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